Axonics, Inc. (NASDAQ:AXNX) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Axonics Third Quarter 2023 Results Conference Call.
Axonics Inc. (AXNX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Alpine Associates Robert Emil Zoellner | 1,814,771 | $125,164,755 | 4.87% | |
| 2. | Millennium Management Israel Englander | 1,190,140 | $82,083,956 | +36385% | 0.03% |
| 3. | Magnetar Capital Alec Litowitz And Ross Laser | 1,146,019 | $79,040,930 | +219% | 1.76% |
| 4. | Balyasny Asset Management Dmitry Balyasny | 1,016,459 | $70,105,177 | +173% | 0.12% |
| 5. | Kryger Capital John Melsom | 945,501 | $65,211,204 | 12.15% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.41 | 3,500 | 683,391 | 2019-08-06 | Filing | ||
| $37.12 | 2,000 | 7,000 | 2019-06-27 | Filing | ||
| $15.00 | 866,666 | Large Shareholder, Director | 3,133,332 | 2018-11-02 | Filing | |
| $15.00 | 866,666 | Large Shareholder | 3,557,461 | 2018-11-02 | Filing | |
| $15.00 | 866,666 | Large Shareholder, Director | 3,557,461 | 2018-11-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $67.74 | 11,288 | 34,428 | 2024-01-31 | Filing | ||
| $67.74 | 15,899 | 77,403 | 2024-01-31 | Filing | ||
| $67.74 | 16,615 | 43,450 | 2024-01-31 | Filing | ||
| $67.74 | 3,489 | 43,323 | 2024-01-31 | Filing | ||
| $67.74 | 35,161 | 188,835 | 2024-01-31 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,426,007 | $337,660,406 | 0.02% | |
| 2. | 5,260,830 | $327,381,451 | 0% | |
| 3. | 4,189,817 | $260,732,313 | 0% | |
| 4. | 1,917,133 | $119,303,187 | 0.7% | |
| 5. | 1,833,165 | $114,077,858 | 1.74% |
News See All
13 Stocks to Buy with Exponential Growth
Optimism was prevailing in the US stock market on October 11 as investors were hopeful that the Federal Reserve won’t take a hawkish stance for the rest of the year amid rising bond yields that are ...
Axonics, Inc. (NASDAQ:AXNX) Q2 2023 Earnings Call Transcript
Neil Bhalodkar: Thanks, Victor. Good afternoon and thank you for joining Axonics' Second Quarter 2023 Results Conference Call.
10 Best Economic Recovery Stocks to Buy
In this piece, we will take a look at the ten best economic recovery stocks to buy.
5 Best Revenue Growth Stocks to Buy
In this piece, we will take a look at the five best revenue growth stocks to buy.
What Makes Axonics (AXNX) Unique?
Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Axonics, Inc. (NASDAQ:AXNX) Q1 2023 Earnings Call Transcript
Operator: Thank you for standing by and welcome to the Axonics' First Quarter 2023 Results Conference Call. At this time, all participants are in listen-only mode.
Axonics, Inc. (NASDAQ:AXNX) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to Axonics' Fourth Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only mode.
12 Most Promising Medical Stocks According to Analysts
Regardless of the short-term market situation, the healthcare industry has a huge growth potential.
Should You Invest in Axonics (AXNX)?
Chartwell Investment Partners, an affiliate of Carillon Tower Advisers, an investment management company, released its “Carillon Chartwell Small Cap Growth Fund” third quarter 2022 investor letter...
Billionaire Hedge Funds
